Aralez Bio

Series-A
aralezbio.com Biotech & Healthcare Emeryville, United States
Total Funding $12M
Latest Round $12M Series-A
Last Announced Oct 31, 2024
Investors 10 Backers
Decision Makers 6 Verified

About Aralez Bio

Delivers noncanonical amino acids that transform molecules into medicine using an enzyme platform.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Emeryville, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website aralezbio.com
Domain Registered Date Feb 14, 2019

Social & Network Presence

X / Twitter Profile @aralezbio (500 followers) Created on Feb 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $12,000,000 · Series-A

    startupintros.com

  2. Milestone

    X account created (@aralezbio)

    500 followers

  3. Milestone

    Website domain registered

    aralezbio.com

Investors & Backers

10
Astia
Fifty Years
Freeflow Ventures
Good Growth Capital
Heritage Medical Systems
Impact Science Ventures
Juniper
Paladin
Pineapple Group
Spero Ventures

Funding History

1 Round
Series-A · Oct 31, 2024

Founders & Leadership

5

Christina Boville

Founder

Work email & phone locked Unlock →

David Romney

Co-founder and CTO

Work email & phone locked Unlock →

Frances Arnold

Co-founder and Nobel Laureate

Work email & phone locked Unlock →

Lori Giver

Founder

Work email & phone locked Unlock →

Tina Boville

Co-founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts